Jazz Pharmaceuticals plc (JAZZ) /
The cash flow of Jazz Pharmaceuticals plc over the past 10 years
Chart Jazz Pharmaceuticals plc: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Jazz Pharmaceuticals plc's operating cash flow was $1.36B and its capital expenditures $58.75M, leaving free cash flow of $1.3B. Free cash flow was above zero in all 10 years shown. It ranged from $582.7M in fiscal 2016 to $1.36B in fiscal 2024. Capital expenditures were highest in fiscal 2025, at $58.75M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.36B | $58.75M | $1.3B |
| 2024ended Dec 31, 2024 | $1.4B | $38.07M | $1.36B |
| 2023ended Dec 31, 2023 | $1.09B | $23.96M | $1.07B |
| 2022ended Dec 31, 2022 | $1.27B | $29.05M | $1.24B |
| 2021ended Dec 31, 2021 | $778.51M | $27.64M | $750.87M |
| 2020ended Dec 31, 2020 | $899.65M | $15M | $884.64M |
| 2019ended Dec 31, 2019 | $776.4M | $40.13M | $736.27M |
| 2018ended Dec 31, 2018 | $798.9M | $20.37M | $778.53M |
| 2017ended Dec 31, 2017 | $693.09M | $28.95M | $664.14M |
| 2016ended Dec 31, 2016 | $592.39M | $9.69M | $582.7M |
Fiscal years as Jazz Pharmaceuticals plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Jazz Pharmaceuticals plc
- The revenue of Jazz Pharmaceuticals plc
- The profitability of Jazz Pharmaceuticals plc
- The debt of Jazz Pharmaceuticals plc
- All of Jazz Pharmaceuticals plc's financials, charted
Companies of a similar size
- RBCRBC BEARINGS INCORPORATED
- NBIXNEUROCRINE BIOSCIENCES INC
- SWKSTANLEY BLACK & DECKER, INC.
- PFGCPerformance Food Group Company
- ULSUL Solutions Inc.
Not investment advice. This page shows what Jazz Pharmaceuticals plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.